Oral ketamine vs placebo in patients with cancer-related neuropathic pain
- Fallon, Marie T.
- Wilcock, Andrew
- Kelly, Caroline A.
- Paul, James
- Lewsley, Liz-Anne
- Norrie, John
- Laird, Barry J. A.
Publication date
April 2018
DOI Publisher
American Medical Association (AMA)Abstract
Ketamine hydrochloride is used as an adjuvant treatment for cancer-related neuropathic pain, but evidence of its effectiveness is limited.1 Findings of a large trial investigating the use of ketamine for general cancer pain were negative, but the population studied did not specifically have neuropathic pain. A randomized trial of oral ketamine for cancer-related neuropathic pain has been called for, and the present trial addresses that need
Add to ORKG